Get the Stockscreener App
0.3313
10.94%
-0.0407
After Hours:
.34
0.0087
+2.63%
Co Diagnostics Inc stock is traded at $0.3313, with a volume of 2.10M.
It is down -10.94% in the last 24 hours and down -10.99% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$0.372
Open:
$0.3245
24h Volume:
2.10M
Relative Volume:
0.09
Market Cap:
$12.76M
Revenue:
$7.11M
Net Income/Loss:
$-41.28M
P/E Ratio:
-0.2401
EPS:
-1.38
Net Cash Flow:
$-26.84M
1W Performance:
-18.42%
1M Performance:
-10.99%
6M Performance:
-3.83%
1Y Performance:
-69.88%
1-Day Range:
$0.317
$0.355
1-Week Range:
$0.317
$0.4286
52-Week Range:
$0.2275
$1.55
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.3313 | 22.37M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
130.59 | 224.77B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
102.69 | 155.63B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
362.22 | 142.80B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
95.87 | 123.31B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
86.30 | 49.97B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
What technical models suggest about Co Diagnostics Inc.’s comeback - newser.com
What recovery options are there for Co Diagnostics Inc.Trade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Will Co Diagnostics Inc. stock remain a Wall Street favoriteJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Predicting Co Diagnostics Inc. trend using moving averagesJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com
Is Co Diagnostics Inc. stock a top momentum playJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - TipRanks
Is Co Diagnostics Inc. stock positioned well for digital economyDay Trade & Verified High Yield Trade Plans - Fundação Cultural do Pará
Sentiment analysis tools applied to Co Diagnostics Inc.Risk Management & Technical Pattern Alert System - newser.com
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2025 Earnings Call Transcript - Insider Monkey
What margin trends mean for Co Diagnostics Inc. stockJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - Fundação Cultural do Pará
Chart overlay techniques for tracking Co Diagnostics Inc.July 2025 Sector Moves & Safe Entry Point Alerts - newser.com
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... By GuruFocus - Investing.com Canada
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... - Yahoo Finance
Co-Diagnostics Expands Global Reach and Innovates with AI - TipRanks
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - AOL.com
Why Co Diagnostics Inc. stock could rally in 2025Bond Market & Comprehensive Market Scan Insights - newser.com
Earnings call transcript: Co-Diagnostics Q3 2025 sees revenue drop, stock falls - Investing.com
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Co-Diagnostics Cuts Its Losses And Bets On New Ventures - Finimize
Co-Diagnostics Q3 net loss narrows on lower expenses - MarketScreener
Co-Diagnostics Reports Third Quarter 2025 Financial Results - WV News
Co-Diagnostics Q3 2025 Earnings Preview - MSN
What to Expect from Co-Diagnostics's Earnings - Benzinga
Co Diagnostics Inc Stock Analysis and ForecastFibonacci Extensions & Free Superior Trading Gains - earlytimes.in
Is Co Diagnostics Inc. building a consolidation baseJuly 2025 PostEarnings & Verified Chart Pattern Signals - newser.com
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia – Company AnnouncementFT.com - Financial Times
Utah Governor and BioUtah Recognize Co-Diagnostics for Saudi Arabia Joint Venture Expansion - citybuzz -
Why Co Diagnostics Inc. stock remains on buy lists2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
What’s next for Co Diagnostics Inc. stock priceQuarterly Profit Review & Target Return Focused Stock Picks - newser.com
Co-Diagnostics (MUN:C97) Price Target Decreased by 32.24% to 1.76 - Nasdaq
How Co Diagnostics Inc. stock compares to industry benchmarksQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
MSN Money - MSN
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.78%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):